Lundbeck
HLUN-B.CO
#2578
Rank
C$9.65 B
Marketcap
C$9.73
Share price
0.58%
Change (1 day)
17.08%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): C$1.07 Billion

According to Lundbeck's latest financial reports the company's current earnings are C$3.80 Billion. , an increase over its 2024 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 C$1.07 B38.47%
2024 C$0.77 B25.74%
2023 C$0.61 B21.77%
2022 C$0.50 B31.57%
2021 C$0.38 B-4.61%
2020 C$0.40 B-45.06%
2019 C$0.73 B-34.04%
2018 C$1.11 B12.83%
2017 C$0.98 B93.99%
2016 C$0.50 B-137.28%
2015 -C$1.37 Billion-1246.24%
2014 C$0.11 B-72.36%
2013 C$0.43 B4.38%
2012 C$0.41 B-55.18%
2011 C$0.91 B5.65%
2010 C$0.87 B-5.9%
2009 C$0.92 B